Haemonetics Newsroom

Haemonetics Analyst Ratings

BenzingaJun 12 05:31 ET

Haemonetics Positioned for Strong Growth: Buy Rating Justified Amidst Operational and Financial Optimism

TipRanksMay 14 05:15 ET

Haemonetics Analyst Ratings

BenzingaMay 10 12:52 ET

Haemonetics Analyst Ratings

BenzingaMay 10 05:51 ET

Haemonetics (HAE) Gets a Hold From Needham

TipRanksMay 9 14:15 ET

Haemonetics Analyst Ratings

BenzingaApr 12 10:44 ET

Barrington Research Maintains Outperform on Haemonetics, Maintains $105 Price Target

BenzingaApr 12 10:44 ET

Needham Remains a Hold on Haemonetics (HAE)

TipRanksMar 5 12:20 ET

Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE), Biogen (BIIB) and Axsome Therapeutics (AXSM)

TipRanksFeb 15 01:41 ET

Haemonetics Analyst Ratings

BenzingaFeb 13 09:31 ET

Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Shattuck Labs (STTK)

TipRanksFeb 13 09:20 ET

Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), ALX Oncology Holdings (ALXO)

TipRanksFeb 9 00:40 ET

Needham Sticks to Its Hold Rating for Haemonetics (HAE)

TipRanksFeb 8 13:05 ET

Haemonetics (HAE): Promising Growth in Plasma Segment and International Expansion Fuels Buy Rating Despite Short-Term Concerns

TipRanksNov 6, 2023 01:41 ET

Haemonetics Analyst Ratings

BenzingaNov 3, 2023 12:06 ET

Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Haemonetics (HAE) and CVRx (CVRX)

TipRanksNov 3, 2023 09:20 ET

Barrington Cuts Price Target on Haemonetics to $105 From $114 on 'Macro Concerns', Keeps Outperform Rating

MT NewswiresNov 3, 2023 09:11 ET

Buy Rating for Haemonetics: Consistent Performance, Financial Outperformance and Promising New Products

TipRanksNov 3, 2023 01:06 ET

Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), Optinose (OPTN)

TipRanksOct 11, 2023 09:20 ET

Strategic Acquisition of OpSens Boosts Haemonetics' Growth Prospects: A Buy Rating Analysis

TipRanksOct 10, 2023 10:35 ET